Lung Cancer
C34
Cancer that begins in the lungs, the leading cause of cancer deaths globally.
이 질환 치료에 사용되는 의약품
59개 의약품
Trametinib
Mekinist
Lorlatinib
Lorbrena
Docetaxel Anhydrous
Docetaxel
Gemcitabine Hydrochloride
Gemcitabine
Pembrolizumab And Berahyaluronidase Alfa-Pmph
KEYTRUDA QLEX
Bevacizumab-Awwb
MVASI
Gefitinib
Gefitinib
Adagrasib
KRAZATI
Paclitaxel
Paclitaxel
Docetaxel
Docetaxel
Etoposide
Etoposide
Pemetrexed Disodium
PEMRYDI RTU
Brigatinib
Alunbrig
Vinorelbine
Vinorelbine
Amivantamab-Vmjw
Rybrevant
Paclitaxel Protein-Bound Particles
Paclitaxel protein-bound particles
Pralsetinib
Gavreto
Topotecan
Topotecan
Ensartinib
ENSACOVE
Tarlatamab-Dlle
IMDELLTRA (AMG757)
Zenocutuzumab
BIZENGRI
Ipilimumab
YERVOY
Gemcitabine
Gemcitabine
Pemetrexed
Pemfexy
Encorafenib
BRAFTOVI
Datopotamab Deruxtecan
DATROWAY
Crizotinib
Xalkori
Erlotinib Hydrochloride
Erlotinib
Erlotinib
Erlotinib
Bevacizumab-Maly
ALYMSYS
Alectinib Hydrochloride
ALECENSA
Cemiplimab-Rwlc
LIBTAYO
Capmatinib
TABRECTA
Dacomitinib
Vizimpro
Trilaciclib
COSELA
Bevacizumab-Adcd
Vegzelma
Paclitaxel (Aibumin-Bound)
Paclitaxel
Taletrectinib
IBTROZI
Porfimer Sodium
Photofrin
Osimertinib
TAGRISSO
Lurbinectedin
ZEPZELCA
Tremelimumab
IMJUDO
Binimetinib
MEKTOVI
Atezolizumab
TECENTRIQ
Bevacizumab-Nwgd
JOBEVNE
Topotecan Hydrochloride
topotecan hydrochloride
Etoposide Phosphate
ETOPOPHOS
Fam-Trastuzumab Deruxtecan-Nxki
Enhertu
Nivolumab And Hyaluronidase-Nvhy
OPDIVO QVANTIG
Selpercatinib
RETEVMO
Tepotinib Hydrochloride
TEPMETKO
Necitumumab
Portrazza
Durvalumab
IMFINZI
Pembrolizumab
KEYTRUDA
Bevacizumab
Avastin
Amivantamab And Hyaluronidase-Lpuj (Human Recombinant)
Rybrevant Faspro
Atezolizumab And Hyaluronidase-Tqjs
Tecentriq Hybreza
Bevacizumab-Bvzr
Zirabev
Pemetrexed Dipotassium
PEMETREXED DIPOTASSIUM
Related Conditions
이 목록에는 FDA 승인 용도 및 임상 문헌에 기록된 허가 외 사용이 포함됩니다. 약물 복용을 시작하거나 변경하기 전에 반드시 의료 전문가와 상담하시기 바랍니다.